Opportunities
SCM Lifesciences, equipped with the highest level of research, manufacturing, and quality control know-how, will provide new cell therapy products for the treatment of incurable diseases.
Cell Therapy
Way Maker
Securing cGMP and Global Pipeline simultaneously through mergers and acquisitions of Co-Immune and Formula through rapid decision-making
leading innovation
Securing iPSC Pipeline and Tissue
Engineering Conducting Cell Sheet research
source technology
through the layer separation method.
Isolation of high-purity and high-potency stem cells
reduction
3D Bioreactor Establishment of mass
production manufacturing process technology
-
282022.01
SCM Life Science has completed recruiting patients with phase 2a clini..
SCM Life Science (SCM Life Science, 298060, CEO Sun Uk Song), a company specializing in research and development of cel..
-
282022.01
“SCM Life Science, Expectations for listing and clinical performance o..
On the 15th, Korea Investment & Securities expected full-scale disclosure of clinical results and technology trans..
-
282022.01
SCM Life Science “Results of phase 2 acute pancreatitis and atopic der..
"Next year is a year to prepare for the release of treatments in 2023. Based on the results of phase 2 clinical t..
We will improve the value of your investment.